Wengel Kathryn E 4
4 · JOHNSON & JOHNSON · Filed Feb 9, 2026
Research Summary
AI-generated summary of this filing
Johnson & Johnson (JNJ) EVP Kathryn Wengel Exercises Options
What Happened
- Kathryn E. Wengel, EVP and Chief TO & Risk Officer at Johnson & Johnson, exercised stock options on 2026-02-06. She acquired 38,945 shares at an exercise price of $101.87 per share (total value $3,967,327). To cover the exercise price and tax obligations, 27,270 shares were withheld/sold at $239.99 per share (proceeds $6,544,527). The Form 4 shows the option exercise and the corresponding share withholding/disposition.
Key Details
- Transaction date: 2026-02-06.
- Option exercise: 38,945 shares @ $101.87 — reported value $3,967,327 (code M).
- Withholding/disposition for taxes/exercise: 27,270 shares @ $239.99 — reported value $6,544,527 (code F).
- Implied net shares retained from this transaction: 11,675 shares (38,945 acquired − 27,270 withheld), based on the reported entries; final beneficial ownership after the transaction is not provided in the excerpt.
- Relevant footnotes:
- F1: Options were auto‑exercised immediately prior to expiration.
- F2: Shares were withheld to pay the exercise price and taxes.
- F3/F4: References to shares held/accumulated in the J&J Savings Plan (as of 1/31/2026).
- Filing: Report filed 2026-02-09 for a 2026-02-06 transaction — appears to be timely.
Context
- This was an option exercise with shares withheld to cover costs (a common, routine corporate action often described as a cashless/net share settlement), not an open‑market purchase or discretionary sale that would necessarily signal personal market sentiment. The Form 4 records both the derivative exercise (M) and the withholding/disposition for taxes/exercise (F) so readers can see the gross exercise and the shares used to satisfy obligations.
Insider Transaction Report
Form 4
Wengel Kathryn E
EVP, Chief TO and Risk Officer
Transactions
- Exercise/Conversion
Common Stock
[F1]2026-02-06$101.87/sh+38,945$3,967,327→ 133,225.874 total - Tax Payment
Common Stock
[F2]2026-02-06$239.99/sh−27,270$6,544,527→ 105,955.874 total - Exercise/Conversion
Employee Stock Options (Right to Buy)
[F1]2026-02-06$101.87/sh−38,945$3,967,327→ 0 totalExercise: $101.87From: 2019-02-09Exp: 2026-02-08→ Common Stock (38,945 underlying)
Holdings
- 281(indirect: By ESOP)
Common Stock
[F3] - 86(indirect: By 401(k))
Common Stock
[F4]
Footnotes (4)
- [F1]Reflects the auto-exercise of options immediately prior to their expiration.
- [F2]Shares withheld for payment of the exercise price and taxes in connection with the exercise of the options reported on this Form 4.
- [F3]Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2026).
- [F4]Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2026).
Signature
/s/ Joleen Morgan, as attorney-in-fact for Kathryn E. Wengel|2026-02-09